COVID-19: Fujifilm ､Avigan clinical trials: Completed in a month
[Tokyo 13th Reuters]
FUJIFILM Holdings:
On August 13, the clinical trial (clinical trial) of “Abigan” was completed approximately one month later, and it is expected that the data necessary for approval will be available.
Junji Okada said at an online conference on the same day.
The final clinical trial from 16th:
Until now, the trial patients were not gathered and the plan was delayed.
“The impact of infection the number of people increased, the number of patients ensure necessary in the trial, the prospect is with” that.
The final clinical trial will start on August 16.
After an observation period of about one month, “all the data are available,” he said.
After data analysis, we will work on the approval and application timing with the authorities in the future.
Reuters
https://jp.reuters.com/article/fujifilm-avigan-idJPKCN2590VN
New Corona: Avigan clinical trial completed in September
Fuji film
It was revealed that the clinical trial (clinical trial) of the drug candidate “Abigan” for the new coronavirus infection conducted by Fujifilm Holdings in Japan is expected to be completed in September.
Initially it was aiming for completion in June, but the plan was delayed due to the lack of participants in the trial.
Nihon Keizai Shimbun
https://r.nikkei.com/article/DGXMZO62532830R10C20A8TJ2000?s=4
Fujifilm-Sponsored Avigan Trial to Complete Enrollment on Aug. 16
Fujifilm Toyama Chemical
plans to complete the patient enrollment on August 16 for its stalled PIII clinical trial in Japan for its antiviral agent Avigan (favipiravir) for the treatment of COVID-19, a company official said.
PHARMA JAPAN